von Willebrand Disease

Media Library

Multiple Functions of VWF

Dr. Ferdows Atiq, MD, MSc, PhD
Consultant Hematologist and Senior Researcher
Royal College of Surgeons in Ireland
Dublin, Ireland

Animal Models of VWD

Cécile V. Denis, PhD
Director of Research, Inserm U1176
University of Paris-Saclay
Le Kremlin-Bicêtre, France

Cellular Models for VWF Investigation

Mackenzie Bowman, PhD
Research Associate
Clinical and Molecular Hemostasis Research Group
Department of Medicine, Queen’s University
Kingston, Canada

Pharmacokinetics of VWF Concentrate Use

Robert Sidonio Jr., MD, MSc
Associate Director of Hemostasis and Thrombosis
Emory University School of Medicine
Atlanta, Georgia

Clinical Genetic Testing for VWD

Jill Johnsen, MD
Physician Scientist, Professor of Medicine
University of Washington
Seattle, Washington

Novel Therapies for VWD

Peter J. Lenting, PhD
Director of Research, Inserm U1176
University of Paris-Saclay
Le Kremlin-Bicêtre, France

Peri-procedural Management of VWD

Frank Leebeek, MD, PhD
Professor, Head of Department of Hematology
Erasmus University Medical Center
Rotterdam, Netherlands

VWD and Women’s Bleeding Disorders

Bethany Samuelson-Bannow, MD, MCR
Program Leader of Classical Hematology
Cleveland Clinic Foundation
Cleveland, Ohio

Genomic Editing Approaches to Treating VWD

Jeroen Eikenboom, MD, PhD
Professor, Division of Thrombosis and Hemostasis
Leiden University Medical Center
Leiden, Netherlands

VWD and Angiogenesis

Anna Randi, MD, PhD
Professor of Cardiovascular Medicine
Imperial College London
London, United Kingdom

The Use of DDAVP in VWD

Saskia E.M. Schols, MD, PhD
Internist/Hematologist
Hemophilia Treatment Center
Nijmegen-Eindhoven-Maastricht
The Netherlands